Dr.Reddy's Laboratories Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dr.Reddy's Laboratories Ltd with three other
pharmaceutical manufacturers in North America:
Prestige Brands Holdings, Incorporation
sales of $882.06 million
of which 82%
was North Ameriican OTC Healthcare),
Peregrine Pharmaceuticals, Inc.
of which 100%
was Contract Manufacturing and Development o), and
Dr.Reddy's Laboratories Ltd reported sales of $2.10 billion
March of 2017.
decrease of 10.8%
versus 2016, when the company's sales were $2.36 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Dr.Reddy's Laboratories Ltd had sales
of $2.02 billion.
Contributing to the drop in overall sales was the 12.9% decline
in Proprietary Products, from $40.55 million to $35.30 million.
There were also decreases in sales in
Global Generics (down 11.7% to $1.72 billion)
Active Pharmaceutical Ingredients and In (down 6.9% to $317.88 million)
However, these declines were partially offset by the increase in sales of
Others (up 7.2% to $26.29 million)